Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 28.
doi: 10.1007/s11010-025-05316-w. Online ahead of print.

Nuclear-localized metabolic enzymes: emerging key players in tumor epigenetic regulation

Limei Chen #  1 , Zhihui Wu #  2 , Weixi Yuan  3 , Nan Chen  2 , Peina Lin  2 , Senyi Liao  3 , Guopeng Xie  4
Affiliations
Review

Nuclear-localized metabolic enzymes: emerging key players in tumor epigenetic regulation

Limei Chen et al. Mol Cell Biochem. .

Abstract

Advancements in tumor research have highlighted the potential of epigenetic therapies as a targeted approach to cancer treatment. However, the application of these therapies has faced challenges due to the issue of substrate availability since the discovery of epigenetic modifications. Interestingly, metabolic changes are closely associated with epigenetic changes, and notably, certain metabolic enzymes exhibit nuclear localization within epigenetically active cellular contexts. This suggests that nuclear localization of metabolic enzymes may provide a mechanistic foundation for addressing substrate availability issues in epigenetic regulation. To date, there has been limited progress in synthesizing this information systematically. In this study, we provide an overview of the interplay between metabolic enzymes and epigenetic mechanisms, highlighting their critical roles. Subsequently, we summarize recent advances regarding the nuclear localization of metabolic enzymes, shedding light on their emerging roles in epigenetic regulation and oncogenesis.

Keywords: DNA demethylation; Epigenetic modifications; Histone modifications; Lactylation; Nuclear localization of metabolic enzymes.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethical approval: This study did not involve the participation of human or animal subjects, and, therefore, was exempt from formal assessment by the ethics committee for clinical research of our center. Consent for publication: Not applicable.

Similar articles

See all similar articles

References

    1. Allis CD, Jenuwein T (2016) The molecular hallmarks of epigenetic control. Nat Rev Genet 17(8):487–500. https://doi.org/10.1038/nrg.2016.59 - DOI - PubMed
    1. Mashtalir N, Suzuki H, Farrell DP, Sankar A, Luo J, Filipovski M, D’Avino AR, St Pierre R, Valencia AM, Onikubo T, Roeder RG, Han Y, He Y, Ranish JA, DiMaio F, Walz T, Kadoch C (2020) A structural model of the endogenous human BAF complex informs disease mechanisms. Cell 183(3):802-817.e24. https://doi.org/10.1016/j.cell.2020.09.051 - DOI - PubMed - PMC
    1. Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31–46. https://doi.org/10.1158/2159-8290.CD-21-1059 - DOI - PubMed
    1. Baylin SB, Jones PA (2016) Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol 8(9):a019505. https://doi.org/10.1101/cshperspect.a019505 - DOI - PubMed - PMC
    1. Xu X, Peng Q, Jiang X, Tan S, Yang Y, Yang W, Han Y, Chen Y, Oyang L, Lin J, Xia L, Peng M, Wu N, Tang Y, Li J, Liao Q, Zhou Y (2023) Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp Mol Med 55(7):1357–1370. https://doi.org/10.1038/s12276-023-01020-1 - DOI - PubMed - PMC

LinkOut - more resources